United States · Bill · S
S. 2329 (118th)
Emerging Pathogen Preparedness Program Authorization Act
Introduced
13 July 2023
Last action
—
Status
Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
Sponsors
—
Subjects
Discovery layer
Source updated
27 May 2025
Summary
Emerging Pathogen Preparedness Program Authorization Act This bill establishes a program in the Food and Drug Administration's Center for Biologics Evaluation and Research to support the development and approval of biological countermeasures. Authorized activities include the development of quality measures for countermeasures, surveillance programs to monitor countermeasures, and research and development of platform vaccine technology to support emergency use authorization requests.
This text is taken from the official record. PoliticalRepo does not editorialize.
Timeline
No timeline events have been ingested for this record yet.
Votes
No vote records are attached yet.
Versions
No version snapshots stored. Document URLs remain at the source.
Documents
3 official files
Introduced in Senate (text)
Introduced in Senate (text)
Introduced in Senate · EN · 13 July 2023
Introduced in Senate (PDF)
Introduced in Senate · EN · 13 July 2023
Introduced in Senate
summary · EN · 13 July 2023
Sponsors
No sponsors or actors listed by the source.
Related records
No cross-record relationships stored yet.
Sources
PoliticalRepo is an index and interpretation layer, not the authoritative legal source.
- Official source: https://www.congress.gov/bill/118th-congress/senate-bill/2329
- Open data entity: https://api.congress.gov/v3/bill/118/s/2329